Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: A preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 database

Journal of Thoracic Oncology

Volumn 1, Issue 7, 2006, Pages 667-672

  Ball, David L ^a   Fisher, Richard ^b   Burmeister, Bryan ^b   Graham, Peter ^b   Joseph, David ^b   Penniment, Michael ^b   Krawitz, Hedley ^b   Wheeler, Greg ^b   Poulsen, Michael ^b   Vinod, Shalini ^b   McClure, Bev ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b NONE

Author keywords

Non small cell lung cancer; Staging; Tumor volume

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DATA ANALYSIS; DATA BASE; FEMALE; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE; MALE; METHODOLOGY; MULTICENTER STUDY; OBSERVATIONAL STUDY; ONCOLOGY; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; TREATMENT PLANNING; TUMOR VOLUME; LUNG TUMOR; LYMPH NODE METASTASIS; PATHOLOGY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; TUMOR BURDEN;

EID: 34247846312     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200609000-00011     Document Type: Article

References (11)

1. Dubben HH, Thames HD, Beck-Bornholdt HP. Tumor volume: A basic and specific response predictor in radiotherapy. Radiother Oncol 1998;47:167-174.
2. Wigren T. Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer. Radiother Oncol 1997;44:9-15.
3. Clamon G, Herndon J, Cooper R, et al. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 1999;17:4-11.
4. Bradley JD, Ieumwananonthachai N, Purdy JA, et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2002;52:49-57.
5. Ball D, Smith J, Wirth A, et al. Failure of T stage to predict survival in patients with non-small-cell lung cancer treated by radiotherapy with or without concomitant chemotherapy. Int J Radiat Oncol Biol Phys 2002;54:1007-1013.
6. Bowden P, Fisher R, Mac Manus M, et al. Measurement of lung tumor volumes using three-dimensional computer planning software. Int J Radiat Oncol Biol Phys 2002;53:566-573.
7. Cole TJ. Sympercents: Symmetric percentage differences on the 100 log(e) scale simplify the presentation of log transformed data. Stat Med 2000;19:3109-3125.
8. Martel MK, Strawderman M, Hazuka MB, et al. Volume and dose parameters for survival of non-small cell lung cancer patients. Radiother Oncol 1997;44:23-29.
9. Basaki K, Abe Y, Aoki M, et al. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume. Int J Radiat Oncol Biol Phys 2006;64:449-454.
10. Heyneman L, Philip JEH, Goodman C, Patz Jr EF. Stage distribution in patients with a small (< or = 3 cm) primary nonsmall cell lung carcinoma. Cancer 2001;92:3051-3055.
11. Harris K, Adams H, Lloyd DC, Harvey DJ. The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings. Clin Radiol 1993;47:241-244.